nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.112	0.351	CbGbCtD
Pethidine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0482	0.15	CbGbCtD
Pethidine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0372	0.116	CbGbCtD
Pethidine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0345	0.108	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0323	0.101	CbGbCtD
Pethidine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0159	0.0495	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0156	0.0487	CbGbCtD
Pethidine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0145	0.0454	CbGbCtD
Pethidine—Etomidate—SLC2A1—peripheral nervous system neoplasm	0.0134	0.768	CrCbGaD
Pethidine—GRIN2C—nerve—peripheral nervous system neoplasm	0.0127	0.0912	CbGeAlD
Pethidine—GRIN1—ganglion—peripheral nervous system neoplasm	0.0104	0.0746	CbGeAlD
Pethidine—GRIN2B—nerve—peripheral nervous system neoplasm	0.01	0.0721	CbGeAlD
Pethidine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00991	0.0309	CbGbCtD
Pethidine—GRIN2B—ganglion—peripheral nervous system neoplasm	0.00991	0.0712	CbGeAlD
Pethidine—GRIN2A—nerve—peripheral nervous system neoplasm	0.00877	0.063	CbGeAlD
Pethidine—GRIN2A—ganglion—peripheral nervous system neoplasm	0.00866	0.0622	CbGeAlD
Pethidine—GRIN2C—brainstem—peripheral nervous system neoplasm	0.00545	0.0391	CbGeAlD
Pethidine—OPRM1—nerve—peripheral nervous system neoplasm	0.00533	0.0383	CbGeAlD
Pethidine—OPRM1—ganglion—peripheral nervous system neoplasm	0.00526	0.0378	CbGeAlD
Pethidine—GRIN2D—brainstem—peripheral nervous system neoplasm	0.00507	0.0364	CbGeAlD
Pethidine—SLC6A3—nerve—peripheral nervous system neoplasm	0.00484	0.0348	CbGeAlD
Pethidine—SLC6A3—ganglion—peripheral nervous system neoplasm	0.00478	0.0343	CbGeAlD
Pethidine—GRIN1—brainstem—peripheral nervous system neoplasm	0.00451	0.0324	CbGeAlD
Pethidine—SLC6A4—ganglion—peripheral nervous system neoplasm	0.00438	0.0315	CbGeAlD
Pethidine—GRIN2B—brainstem—peripheral nervous system neoplasm	0.00431	0.0309	CbGeAlD
Pethidine—SLC6A2—nerve—peripheral nervous system neoplasm	0.0039	0.028	CbGeAlD
Pethidine—SLC6A2—ganglion—peripheral nervous system neoplasm	0.00385	0.0277	CbGeAlD
Pethidine—GRIN2A—brainstem—peripheral nervous system neoplasm	0.00376	0.027	CbGeAlD
Pethidine—Cyclopentolate—BCHE—peripheral nervous system neoplasm	0.00273	0.157	CrCbGaD
Pethidine—GRIN2C—cerebellum—peripheral nervous system neoplasm	0.00269	0.0193	CbGeAlD
Pethidine—GRIN2D—cerebellum—peripheral nervous system neoplasm	0.0025	0.0179	CbGeAlD
Pethidine—OPRM1—brainstem—peripheral nervous system neoplasm	0.00229	0.0164	CbGeAlD
Pethidine—GRIN1—cerebellum—peripheral nervous system neoplasm	0.00223	0.016	CbGeAlD
Pethidine—GRIN2B—cerebellum—peripheral nervous system neoplasm	0.00212	0.0153	CbGeAlD
Pethidine—SLC6A3—brainstem—peripheral nervous system neoplasm	0.00208	0.0149	CbGeAlD
Pethidine—SLC6A4—brainstem—peripheral nervous system neoplasm	0.0019	0.0137	CbGeAlD
Pethidine—GRIN2A—cerebellum—peripheral nervous system neoplasm	0.00186	0.0133	CbGeAlD
Pethidine—SLC6A2—brainstem—peripheral nervous system neoplasm	0.00168	0.012	CbGeAlD
Pethidine—OPRK1—cerebellum—peripheral nervous system neoplasm	0.00159	0.0114	CbGeAlD
Pethidine—Levomilnacipran—ABCB1—peripheral nervous system neoplasm	0.0013	0.0746	CrCbGaD
Pethidine—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.00102	0.00736	CbGeAlD
Pethidine—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000917	0.00659	CbGeAlD
Pethidine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000886	0.00238	CcSEcCtD
Pethidine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000871	0.00234	CcSEcCtD
Pethidine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000871	0.00234	CcSEcCtD
Pethidine—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.000859	0.00231	CcSEcCtD
Pethidine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.000858	0.00231	CcSEcCtD
Pethidine—Coordination abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000858	0.00231	CcSEcCtD
Pethidine—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.000853	0.00229	CcSEcCtD
Pethidine—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.000852	0.00229	CcSEcCtD
Pethidine—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.000852	0.00229	CcSEcCtD
Pethidine—Constipation—Topotecan—peripheral nervous system neoplasm	0.000845	0.00227	CcSEcCtD
Pethidine—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000841	0.00226	CcSEcCtD
Pethidine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.000838	0.00225	CcSEcCtD
Pethidine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.000838	0.00225	CcSEcCtD
Pethidine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000836	0.00225	CcSEcCtD
Pethidine—Coma—Epirubicin—peripheral nervous system neoplasm	0.000832	0.00224	CcSEcCtD
Pethidine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000827	0.00222	CcSEcCtD
Pethidine—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000816	0.00219	CcSEcCtD
Pethidine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000814	0.00219	CcSEcCtD
Pethidine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000808	0.00217	CcSEcCtD
Pethidine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000808	0.00217	CcSEcCtD
Pethidine—Agitation—Vincristine—peripheral nervous system neoplasm	0.000806	0.00216	CcSEcCtD
Pethidine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000804	0.00216	CcSEcCtD
Pethidine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000801	0.00215	CcSEcCtD
Pethidine—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.0008	0.00215	CcSEcCtD
Pethidine—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000789	0.00212	CcSEcCtD
Pethidine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.000788	0.00212	CcSEcCtD
Pethidine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000786	0.00211	CcSEcCtD
Pethidine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000785	0.00211	CcSEcCtD
Pethidine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000779	0.00209	CcSEcCtD
Pethidine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000779	0.00209	CcSEcCtD
Pethidine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000775	0.00208	CcSEcCtD
Pethidine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000772	0.00207	CcSEcCtD
Pethidine—Coma—Doxorubicin—peripheral nervous system neoplasm	0.00077	0.00207	CcSEcCtD
Pethidine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000769	0.00206	CcSEcCtD
Pethidine—Phlebitis—Epirubicin—peripheral nervous system neoplasm	0.000768	0.00206	CcSEcCtD
Pethidine—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000764	0.00205	CcSEcCtD
Pethidine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00076	0.00204	CcSEcCtD
Pethidine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000758	0.00204	CcSEcCtD
Pethidine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000757	0.00203	CcSEcCtD
Pethidine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000757	0.00203	CcSEcCtD
Pethidine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000749	0.00201	CcSEcCtD
Pethidine—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000746	0.002	CcSEcCtD
Pethidine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000743	0.00199	CcSEcCtD
Pethidine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000743	0.00199	CcSEcCtD
Pethidine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000731	0.00196	CcSEcCtD
Pethidine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000728	0.00195	CcSEcCtD
Pethidine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000727	0.00195	CcSEcCtD
Pethidine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000725	0.00195	CcSEcCtD
Pethidine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000722	0.00194	CcSEcCtD
Pethidine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000722	0.00194	CcSEcCtD
Pethidine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000718	0.00193	CcSEcCtD
Pethidine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000716	0.00192	CcSEcCtD
Pethidine—Oedema—Vincristine—peripheral nervous system neoplasm	0.000716	0.00192	CcSEcCtD
Pethidine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000713	0.00191	CcSEcCtD
Pethidine—Phlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00191	CcSEcCtD
Pethidine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000709	0.0019	CcSEcCtD
Pethidine—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000708	0.0019	CcSEcCtD
Pethidine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000703	0.00189	CcSEcCtD
Pethidine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000703	0.00189	CcSEcCtD
Pethidine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000699	0.00188	CcSEcCtD
Pethidine—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000696	0.00187	CcSEcCtD
Pethidine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000694	0.00186	CcSEcCtD
Pethidine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000694	0.00186	CcSEcCtD
Pethidine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000693	0.00186	CcSEcCtD
Pethidine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000693	0.00186	CcSEcCtD
Pethidine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000692	0.00186	CcSEcCtD
Pethidine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000684	0.00184	CcSEcCtD
Pethidine—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000683	0.00183	CcSEcCtD
Pethidine—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000682	0.00183	CcSEcCtD
Pethidine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000672	0.0018	CcSEcCtD
Pethidine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000672	0.0018	CcSEcCtD
Pethidine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000669	0.0018	CcSEcCtD
Pethidine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00066	0.00177	CcSEcCtD
Pethidine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00066	0.00177	CcSEcCtD
Pethidine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000658	0.00177	CcSEcCtD
Pethidine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000653	0.00175	CcSEcCtD
Pethidine—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000651	0.00175	CcSEcCtD
Pethidine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000648	0.00174	CcSEcCtD
Pethidine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000648	0.00174	CcSEcCtD
Pethidine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000647	0.00174	CcSEcCtD
Pethidine—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000646	0.00173	CcSEcCtD
Pethidine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000638	0.00171	CcSEcCtD
Pethidine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000635	0.00171	CcSEcCtD
Pethidine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000633	0.0017	CcSEcCtD
Pethidine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000633	0.0017	CcSEcCtD
Pethidine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000629	0.00169	CcSEcCtD
Pethidine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000628	0.00169	CcSEcCtD
Pethidine—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000626	0.00168	CcSEcCtD
Pethidine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000624	0.00168	CcSEcCtD
Pethidine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000623	0.00167	CcSEcCtD
Pethidine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000623	0.00167	CcSEcCtD
Pethidine—Rash—Topotecan—peripheral nervous system neoplasm	0.000623	0.00167	CcSEcCtD
Pethidine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000622	0.00167	CcSEcCtD
Pethidine—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000622	0.00167	CcSEcCtD
Pethidine—Headache—Topotecan—peripheral nervous system neoplasm	0.000619	0.00166	CcSEcCtD
Pethidine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000618	0.00166	CcSEcCtD
Pethidine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000618	0.00166	CcSEcCtD
Pethidine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000618	0.00166	CcSEcCtD
Pethidine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000617	0.00166	CcSEcCtD
Pethidine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000617	0.00166	CcSEcCtD
Pethidine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000616	0.00165	CcSEcCtD
Pethidine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000615	0.00165	CcSEcCtD
Pethidine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000614	0.00165	CcSEcCtD
Pethidine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000614	0.00165	CcSEcCtD
Pethidine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000613	0.00165	CcSEcCtD
Pethidine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000612	0.00164	CcSEcCtD
Pethidine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000612	0.00164	CcSEcCtD
Pethidine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000612	0.00164	CcSEcCtD
Pethidine—Rash—Melphalan—peripheral nervous system neoplasm	0.00061	0.00164	CcSEcCtD
Pethidine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000609	0.00164	CcSEcCtD
Pethidine—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000604	0.00162	CcSEcCtD
Pethidine—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000603	0.00162	CcSEcCtD
Pethidine—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.000602	0.00162	CcSEcCtD
Pethidine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000591	0.00159	CcSEcCtD
Pethidine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00059	0.00159	CcSEcCtD
Pethidine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00059	0.00158	CcSEcCtD
Pethidine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000587	0.00158	CcSEcCtD
Pethidine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000585	0.00157	CcSEcCtD
Pethidine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000582	0.00156	CcSEcCtD
Pethidine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000582	0.00156	CcSEcCtD
Pethidine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000582	0.00156	CcSEcCtD
Pethidine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00058	0.00156	CcSEcCtD
Pethidine—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.00058	0.00156	CcSEcCtD
Pethidine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000575	0.00154	CcSEcCtD
Pethidine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000575	0.00154	CcSEcCtD
Pethidine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000566	0.00152	CcSEcCtD
Pethidine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000561	0.00151	CcSEcCtD
Pethidine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.0015	CcSEcCtD
Pethidine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000553	0.00148	CcSEcCtD
Pethidine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00055	0.00148	CcSEcCtD
Pethidine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000547	0.00147	CcSEcCtD
Pethidine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000542	0.00145	CcSEcCtD
Pethidine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000533	0.00143	CcSEcCtD
Pethidine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000527	0.00142	CcSEcCtD
Pethidine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000526	0.00141	CcSEcCtD
Pethidine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000522	0.0014	CcSEcCtD
Pethidine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000515	0.00138	CcSEcCtD
Pethidine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000514	0.00138	CcSEcCtD
Pethidine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00051	0.00137	CcSEcCtD
Pethidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000509	0.00137	CcSEcCtD
Pethidine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000505	0.00136	CcSEcCtD
Pethidine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000504	0.00135	CcSEcCtD
Pethidine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000496	0.00133	CcSEcCtD
Pethidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000491	0.00132	CcSEcCtD
Pethidine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000489	0.00131	CcSEcCtD
Pethidine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000478	0.00128	CcSEcCtD
Pethidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000476	0.00128	CcSEcCtD
Pethidine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000473	0.00127	CcSEcCtD
Pethidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000472	0.00127	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000472	0.00127	CcSEcCtD
Pethidine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00126	CcSEcCtD
Pethidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000468	0.00126	CcSEcCtD
Pethidine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000466	0.00125	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000466	0.00125	CcSEcCtD
Pethidine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000465	0.00125	CcSEcCtD
Pethidine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000461	0.00124	CcSEcCtD
Pethidine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000455	0.00122	CcSEcCtD
Pethidine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000454	0.00122	CcSEcCtD
Pethidine—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000452	0.00325	CbGeAlD
Pethidine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.00121	CcSEcCtD
Pethidine—Rash—Vincristine—peripheral nervous system neoplasm	0.000451	0.00121	CcSEcCtD
Pethidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000451	0.00121	CcSEcCtD
Pethidine—Headache—Vincristine—peripheral nervous system neoplasm	0.000448	0.0012	CcSEcCtD
Pethidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000441	0.00118	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000441	0.00118	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.00116	CcSEcCtD
Pethidine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000427	0.00115	CcSEcCtD
Pethidine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000425	0.00114	CcSEcCtD
Pethidine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000425	0.00114	CcSEcCtD
Pethidine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000416	0.00112	CcSEcCtD
Pethidine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00041	0.0011	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.0011	CcSEcCtD
Pethidine—GRIN2D—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000407	0.0027	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000403	0.00268	CbGpPWpGaD
Pethidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000402	0.00108	CcSEcCtD
Pethidine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000399	0.00107	CcSEcCtD
Pethidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000399	0.00107	CcSEcCtD
Pethidine—SLC6A4—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000399	0.00265	CbGpPWpGaD
Pethidine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000398	0.00107	CcSEcCtD
Pethidine—SLC6A4—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000397	0.00263	CbGpPWpGaD
Pethidine—SLC6A3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000396	0.00263	CbGpPWpGaD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000396	0.00263	CbGpPWpGaD
Pethidine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.00105	CcSEcCtD
Pethidine—GRIN1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000392	0.0026	CbGpPWpGaD
Pethidine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000383	0.00103	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000383	0.00103	CcSEcCtD
Pethidine—GRIN2B—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000382	0.00254	CbGpPWpGaD
Pethidine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000376	0.00101	CcSEcCtD
Pethidine—OPRK1—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.00037	0.00246	CbGpPWpGaD
Pethidine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000369	0.00099	CcSEcCtD
Pethidine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.00099	CcSEcCtD
Pethidine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000983	CcSEcCtD
Pethidine—Rash—Etoposide—peripheral nervous system neoplasm	0.000366	0.000982	CcSEcCtD
Pethidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000365	0.000981	CcSEcCtD
Pethidine—Headache—Etoposide—peripheral nervous system neoplasm	0.000363	0.000975	CcSEcCtD
Pethidine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000358	0.000961	CcSEcCtD
Pethidine—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000959	CcSEcCtD
Pethidine—OPRM1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000356	0.00236	CbGpPWpGaD
Pethidine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000951	CcSEcCtD
Pethidine—SLC6A4—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000353	0.00234	CbGpPWpGaD
Pethidine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000352	0.000945	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00035	0.00094	CcSEcCtD
Pethidine—OPRM1—TCR Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.000346	0.00229	CbGpPWpGaD
Pethidine—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000927	CcSEcCtD
Pethidine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000344	0.000925	CcSEcCtD
Pethidine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000923	CcSEcCtD
Pethidine—SLC6A2—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000343	0.00227	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000341	0.00226	CbGpPWpGaD
Pethidine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000909	CcSEcCtD
Pethidine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000907	CcSEcCtD
Pethidine—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000335	0.00222	CbGpPWpGaD
Pethidine—GRIN2A—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000334	0.00222	CbGpPWpGaD
Pethidine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000332	0.00089	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000889	CcSEcCtD
Pethidine—GRIN1—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000331	0.0022	CbGpPWpGaD
Pethidine—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00033	0.000887	CcSEcCtD
Pethidine—GRIN1—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.00033	0.00219	CbGpPWpGaD
Pethidine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000328	0.00088	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.000874	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000873	CcSEcCtD
Pethidine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000873	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.00087	CcSEcCtD
Pethidine—SLC6A3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000323	0.00214	CbGpPWpGaD
Pethidine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000323	0.00214	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000322	0.00214	CbGpPWpGaD
Pethidine—Shock—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000859	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000857	CcSEcCtD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000319	0.00212	CbGpPWpGaD
Pethidine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.000854	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000852	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000314	0.000844	CcSEcCtD
Pethidine—OPRM1—Peptide ligand-binding receptors—KNG1—peripheral nervous system neoplasm	0.000313	0.00208	CbGpPWpGaD
Pethidine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.00084	CcSEcCtD
Pethidine—OPRK1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000312	0.00207	CbGpPWpGaD
Pethidine—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000832	CcSEcCtD
Pethidine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000307	0.00204	CbGpPWpGaD
Pethidine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000824	CcSEcCtD
Pethidine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000816	CcSEcCtD
Pethidine—SLC6A3—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000304	0.00201	CbGpPWpGaD
Pethidine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000814	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000808	CcSEcCtD
Pethidine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000808	CcSEcCtD
Pethidine—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000795	CcSEcCtD
Pethidine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000294	0.000789	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000788	CcSEcCtD
Pethidine—GRIN1—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000291	0.00193	CbGpPWpGaD
Pethidine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000781	CcSEcCtD
Pethidine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000289	0.000776	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.00077	CcSEcCtD
Pethidine—GRIN2B—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000284	0.00189	CbGpPWpGaD
Pethidine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000759	CcSEcCtD
Pethidine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000282	0.00187	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000281	0.00187	CbGpPWpGaD
Pethidine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000755	CcSEcCtD
Pethidine—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000279	0.00185	CbGpPWpGaD
Pethidine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000278	0.000746	CcSEcCtD
Pethidine—GRIN2B—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000274	0.00182	CbGpPWpGaD
Pethidine—OPRK1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000273	0.00181	CbGpPWpGaD
Pethidine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000272	0.00073	CcSEcCtD
Pethidine—SLC6A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000271	0.0018	CbGpPWpGaD
Pethidine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000719	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000267	0.000718	CcSEcCtD
Pethidine—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000265	0.00176	CbGpPWpGaD
Pethidine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000265	0.00176	CbGpPWpGaD
Pethidine—OPRM1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000264	0.00175	CbGpPWpGaD
Pethidine—GRIN1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000264	0.00175	CbGpPWpGaD
Pethidine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000702	CcSEcCtD
Pethidine—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000693	CcSEcCtD
Pethidine—GRIN1—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000257	0.00171	CbGpPWpGaD
Pethidine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000691	CcSEcCtD
Pethidine—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00025	0.00166	CbGpPWpGaD
Pethidine—OPRK1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000248	0.00165	CbGpPWpGaD
Pethidine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000666	CcSEcCtD
Pethidine—SLC6A3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000247	0.00164	CbGpPWpGaD
Pethidine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000246	0.00163	CbGpPWpGaD
Pethidine—GRIN1—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000242	0.00161	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00024	0.00159	CbGpPWpGaD
Pethidine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000643	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000642	CcSEcCtD
Pethidine—OPRK1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000238	0.00158	CbGpPWpGaD
Pethidine—GRIN2B—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000236	0.00157	CbGpPWpGaD
Pethidine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000626	CcSEcCtD
Pethidine—OPRM1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000231	0.00153	CbGpPWpGaD
Pethidine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000618	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000595	CcSEcCtD
Pethidine—GRIN1—Axon guidance—MET—peripheral nervous system neoplasm	0.000222	0.00147	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—MET—peripheral nervous system neoplasm	0.000216	0.00143	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000216	0.00143	CbGpPWpGaD
Pethidine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000579	CcSEcCtD
Pethidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000577	CcSEcCtD
Pethidine—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000214	0.00142	CbGpPWpGaD
Pethidine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000571	CcSEcCtD
Pethidine—GRIN1—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000211	0.0014	CbGpPWpGaD
Pethidine—OPRM1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00021	0.00139	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000207	0.00137	CbGpPWpGaD
Pethidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000555	CcSEcCtD
Pethidine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00055	CcSEcCtD
Pethidine—GRIN1—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000205	0.00136	CbGpPWpGaD
Pethidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00055	CcSEcCtD
Pethidine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000547	CcSEcCtD
Pethidine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000202	0.00134	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000201	0.00133	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.0002	0.00133	CbGpPWpGaD
Pethidine—GRIN2C—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000199	0.00132	CbGpPWpGaD
Pethidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000534	CcSEcCtD
Pethidine—SLC6A4—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000198	0.00131	CbGpPWpGaD
Pethidine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000518	CcSEcCtD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000192	0.00128	CbGpPWpGaD
Pethidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000513	CcSEcCtD
Pethidine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000509	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000509	CcSEcCtD
Pethidine—OPRK1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000189	0.00125	CbGpPWpGaD
Pethidine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000506	CcSEcCtD
Pethidine—GRIN2D—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000185	0.00123	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000182	0.00121	CbGpPWpGaD
Pethidine—OPRM1—IL4-mediated signaling events—AKT1—peripheral nervous system neoplasm	0.000181	0.0012	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00018	0.0012	CbGpPWpGaD
Pethidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00048	CcSEcCtD
Pethidine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000176	0.00117	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000175	0.00116	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000172	0.00114	CbGpPWpGaD
Pethidine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000172	0.00114	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000168	0.00112	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000168	0.00111	CbGpPWpGaD
Pethidine—OPRK1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000165	0.0011	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000164	0.00109	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000162	0.00107	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00016	0.00106	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—MET—peripheral nervous system neoplasm	0.000158	0.00105	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000158	0.00105	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—MET—peripheral nervous system neoplasm	0.000154	0.00102	CbGpPWpGaD
Pethidine—GRIN2C—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000153	0.00101	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000152	0.00101	CbGpPWpGaD
Pethidine—GRIN1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000152	0.00101	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000152	0.00101	CbGpPWpGaD
Pethidine—GRIN2A—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000152	0.00101	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000151	0.001	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.000148	0.000985	CbGpPWpGaD
Pethidine—GRIN2B—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	0.000148	0.000985	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000146	0.00097	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000143	0.00095	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000143	0.000946	CbGpPWpGaD
Pethidine—GRIN2D—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000142	0.000941	CbGpPWpGaD
Pethidine—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000142	0.00094	CbGpPWpGaD
Pethidine—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000141	0.000938	CbGpPWpGaD
Pethidine—OPRM1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00014	0.000927	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000138	0.000918	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000136	0.000903	CbGpPWpGaD
Pethidine—OPRM1—TCR Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000134	0.000891	CbGpPWpGaD
Pethidine—GRIN1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000133	0.00088	CbGpPWpGaD
Pethidine—GRIN2B—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000129	0.000858	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000128	0.000847	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000128	0.000847	CbGpPWpGaD
Pethidine—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	0.000127	0.000846	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000127	0.000842	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000127	0.000842	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.000124	0.00082	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000123	0.000818	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000122	0.000812	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—NRAS—peripheral nervous system neoplasm	0.00012	0.000797	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000117	0.000775	CbGpPWpGaD
Pethidine—GRIN2A—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000116	0.000773	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000116	0.000767	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000115	0.000765	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000113	0.000753	CbGpPWpGaD
Pethidine—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000113	0.00075	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000113	0.000748	CbGpPWpGaD
Pethidine—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000109	0.000724	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000108	0.000715	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000107	0.000709	CbGpPWpGaD
Pethidine—SLC6A4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000104	0.000687	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000103	0.000686	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000102	0.000677	CbGpPWpGaD
Pethidine—GRIN1—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000102	0.000674	CbGpPWpGaD
Pethidine—SLC6A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.0001	0.000665	CbGpPWpGaD
Pethidine—GRIN2B—Neuronal System—HRAS—peripheral nervous system neoplasm	9.9e-05	0.000657	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	9.7e-05	0.000644	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VIP—peripheral nervous system neoplasm	9.67e-05	0.000642	CbGpPWpGaD
Pethidine—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.55e-05	0.000634	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	9.34e-05	0.00062	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	9.03e-05	0.000599	CbGpPWpGaD
Pethidine—GRIN1—Axon guidance—HRAS—peripheral nervous system neoplasm	9.01e-05	0.000598	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	8.92e-05	0.000592	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.79e-05	0.000583	CbGpPWpGaD
Pethidine—GRIN2B—Axon guidance—HRAS—peripheral nervous system neoplasm	8.78e-05	0.000583	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.57e-05	0.000569	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—NRAS—peripheral nervous system neoplasm	8.57e-05	0.000569	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	8.48e-05	0.000563	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	8.25e-05	0.000548	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	8.2e-05	0.000544	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	8.2e-05	0.000544	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VIP—peripheral nervous system neoplasm	8.17e-05	0.000542	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.93e-05	0.000527	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	7.89e-05	0.000524	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.88e-05	0.000523	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	7.86e-05	0.000522	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	7.65e-05	0.000508	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.63e-05	0.000506	CbGpPWpGaD
Pethidine—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	7.57e-05	0.000503	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	7.57e-05	0.000502	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	7.54e-05	0.0005	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.2e-05	0.000478	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	7.17e-05	0.000476	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	7.12e-05	0.000473	CbGpPWpGaD
Pethidine—ALB—Metabolism—GNS—peripheral nervous system neoplasm	6.9e-05	0.000458	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	6.7e-05	0.000445	CbGpPWpGaD
Pethidine—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	6.69e-05	0.000444	CbGpPWpGaD
Pethidine—ALB—Metabolism—NME1—peripheral nervous system neoplasm	6.62e-05	0.000439	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.43e-05	0.000427	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	6.37e-05	0.000423	CbGpPWpGaD
Pethidine—ALB—Metabolism—COX2—peripheral nervous system neoplasm	6.37e-05	0.000423	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—HRAS—peripheral nervous system neoplasm	6.27e-05	0.000416	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	6.2e-05	0.000411	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	5.94e-05	0.000394	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	5.9e-05	0.000391	CbGpPWpGaD
Pethidine—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	5.8e-05	0.000385	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.79e-05	0.000384	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	5.73e-05	0.00038	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	5.72e-05	0.00038	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	5.7e-05	0.000378	CbGpPWpGaD
Pethidine—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.68e-05	0.000377	CbGpPWpGaD
Pethidine—GRIN1—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.68e-05	0.000377	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	5.66e-05	0.000376	CbGpPWpGaD
Pethidine—GRIN2B—Developmental Biology—AKT1—peripheral nervous system neoplasm	5.53e-05	0.000367	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	5.46e-05	0.000363	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	5.46e-05	0.000363	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	5.26e-05	0.000349	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.15e-05	0.000342	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	5.01e-05	0.000333	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	4.98e-05	0.000331	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	4.97e-05	0.00033	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	4.84e-05	0.000321	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	4.65e-05	0.000309	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	4.62e-05	0.000306	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	4.24e-05	0.000281	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	4.2e-05	0.000279	CbGpPWpGaD
Pethidine—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	4.18e-05	0.000278	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	4e-05	0.000266	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	3.95e-05	0.000262	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	3.75e-05	0.000249	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.73e-05	0.000247	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.57e-05	0.000237	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3.54e-05	0.000235	CbGpPWpGaD
Pethidine—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	3.53e-05	0.000235	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	3.5e-05	0.000232	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	3.48e-05	0.000231	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	3.45e-05	0.000229	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.44e-05	0.000228	CbGpPWpGaD
Pethidine—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.37e-05	0.000224	CbGpPWpGaD
Pethidine—ALB—Metabolism—TH—peripheral nervous system neoplasm	3.32e-05	0.00022	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	3.22e-05	0.000214	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	3.17e-05	0.000211	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	3.16e-05	0.00021	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.03e-05	0.000201	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	3e-05	0.000199	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	2.98e-05	0.000198	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.94e-05	0.000195	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.92e-05	0.000194	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	2.79e-05	0.000186	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.78e-05	0.000185	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.75e-05	0.000183	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.74e-05	0.000182	CbGpPWpGaD
Pethidine—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	2.71e-05	0.00018	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	2.66e-05	0.000177	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.59e-05	0.000172	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.52e-05	0.000167	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.5e-05	0.000166	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	2.43e-05	0.000162	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	2.39e-05	0.000159	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.33e-05	0.000154	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.29e-05	0.000152	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.26e-05	0.00015	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	2.24e-05	0.000149	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.2e-05	0.000146	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.19e-05	0.000145	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	2.14e-05	0.000142	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.13e-05	0.000141	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.11e-05	0.00014	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.09e-05	0.000139	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	2.04e-05	0.000136	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.95e-05	0.000129	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.94e-05	0.000128	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.91e-05	0.000127	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.82e-05	0.000121	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	1.81e-05	0.00012	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.79e-05	0.000119	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.77e-05	0.000117	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.65e-05	0.000109	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.6e-05	0.000106	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.53e-05	0.000102	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.46e-05	9.72e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.44e-05	9.54e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.35e-05	8.99e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.35e-05	8.98e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.29e-05	8.59e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.14e-05	7.59e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	8.7e-06	5.77e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	7.32e-06	4.86e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	6.57e-06	4.36e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	6.04e-06	4.01e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.95e-06	2.62e-05	CbGpPWpGaD
